METAvivor funds research that specifically addresses the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer. All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.
METAvivor Research Award: Up to 2 years, $250,000 award for established investigators.
Application Portal Opens: January 25, 2021
Required LOI Deadline: March 26, 2021
Invitations to Submit Full Application: on or by May 19, 2021
Invited Applications Deadline: by 11:59 PM ET on August 25, 2021
Announcement of Awardees: on or by December 17, 2021